tice bcg

Generic: bacillus calmette-guerin

Labeler: merck sharp & dohme llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name tice bcg
Generic Name bacillus calmette-guerin
Labeler merck sharp & dohme llc
Dosage Form POWDER, FOR SUSPENSION
Routes
INTRAVESICAL
Active Ingredients

bacillus calmette-guerin substrain tice live antigen 50 mg/50mL

Manufacturer
Merck Sharp & Dohme LLC

Identifiers & Regulatory

Product NDC 0052-0602
Product ID 0052-0602_21f6d4ee-8165-4c60-9603-67580f1e9f70
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA102821
Listing Expiration 2026-12-31
Marketing Start 1990-08-24

Pharmacologic Class

Established (EPC)
live attenuated bacillus calmette-guerin vaccine [epc] live attenuated bacillus calmette-guerin immunotherapy [epc]
Chemical Structure
vaccines, attenuated [cs] bcg vaccine [cs]
Physiologic Effect
actively acquired immunity [pe] increased macrophage proliferation [pe] increased immunologically active molecule activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00520602
Hyphenated Format 0052-0602

Supplemental Identifiers

RxCUI
213744 1653484
UPC
0300520602020
UNII
2XQ558L16Z
NUI
N0000183904 N0000183364 M0022454 M0002239 N0000183906 N0000183884 N0000009357

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tice bcg (source: ndc)
Generic Name bacillus calmette-guerin (source: ndc)
Application Number BLA102821 (source: ndc)
Routes
INTRAVESICAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/50mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0052-0602-02) / 50 mL in 1 VIAL (0052-0602-01)
source: ndc

Packages (1)

0052-0602-02 1 VIAL in 1 CARTON (0052-0602-02) / 50 mL in 1 VIAL (0052-0602-01)

Ingredients (1)

bacillus calmette-guerin substrain tice live antigen (50 mg/50mL)

Linked Drug Pages (1)

TICE BCG ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVESICAL"], "spl_id": "21f6d4ee-8165-4c60-9603-67580f1e9f70", "openfda": {"nui": ["N0000183904", "N0000183364", "M0022454", "M0002239", "N0000183906", "N0000183884", "N0000009357"], "upc": ["0300520602020"], "unii": ["2XQ558L16Z"], "rxcui": ["213744", "1653484"], "spl_set_id": ["c9b74876-e665-442b-87ad-b7333bc9a67a"], "pharm_class_cs": ["Vaccines, Attenuated [CS]", "BCG Vaccine [CS]"], "pharm_class_pe": ["Actively Acquired Immunity [PE]", "Increased Macrophage Proliferation [PE]", "Increased Immunologically Active Molecule Activity [PE]"], "pharm_class_epc": ["Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]", "Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0052-0602-02)  / 50 mL in 1 VIAL (0052-0602-01)", "package_ndc": "0052-0602-02", "marketing_start_date": "19900824"}], "brand_name": "TICE BCG", "product_id": "0052-0602_21f6d4ee-8165-4c60-9603-67580f1e9f70", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Actively Acquired Immunity [PE]", "BCG Vaccine [CS]", "Increased Immunologically Active Molecule Activity [PE]", "Increased Macrophage Proliferation [PE]", "Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]", "Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]", "Vaccines", "Attenuated [CS]"], "product_ndc": "0052-0602", "generic_name": "BACILLUS CALMETTE-GUERIN", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TICE BCG", "active_ingredients": [{"name": "BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN", "strength": "50 mg/50mL"}], "application_number": "BLA102821", "marketing_category": "BLA", "marketing_start_date": "19900824", "listing_expiration_date": "20261231"}